No black box warning on record for Edurant

As of the latest FDA labeling reviewed, Edurant (RILPIVIRINE HYDROCHLORIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Edurant medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Skin and Hypersensitivity Reactions: Severe skin and hypersensitivity reactions have been reported during postmarketing experience, including cases of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), with rilpivirine-containing regimens. Immediately discontinue treatment if hypersensitivity or rash with systemic symptoms or elevations in hepatic serum bioch

No black box warning on record for Edurant

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Skin and Hypersensitivity Reactions: Severe skin and hypersensitivity reactions have been reported during postmarketing experience, including cases of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), with rilpivirine-containing regimens. Immediately discontinue treatment if hypersensitivity or rash with systemic symptoms or elevations in hepatic serum bioch

Edurant Black Box Warning

No black box warning on record for Edurant

Other warnings & precautions

Edurant Black Box Warning

No black box warning on record for Edurant

Other warnings & precautions